A Novel Cytotherapy Device for Rapid Screening, Enriching and Combining Mesenchymal Stem Cells into a Biomaterial for Promoting Bone Regeneration

Yifu Zhuang,Yaokai Gan,Dingwei Shi,Jie Zhao,Tingting Tang,Kerong Dai
DOI: https://doi.org/10.1038/s41598-017-15451-0
IF: 4.6
2017-01-01
Scientific Reports
Abstract:Bone defects are a common challenge in clinic, usually warranting bone grafts. However, current strategies to obtain effective graft materials have many drawbacks. Mesenchymal stem cell (MSC)-based therapy is a promising alternative. We designed an innovative appliance named the stem cell screen–enrich–combine(-biomaterials) circulating system (SECCS). In this study, 42 patients who required bone graft underwent SECCS-based treatment. Their bone marrow samples and beta-tricalcium phosphate (β-TCP) granules were processed in the SECCS for 10–15 minutes, to produce MSC/β-TCP composites. These composites were grafted back into bone defect sites. The results showed 85.53% ± 7.95% autologous MSCs were successfully screened, enriched, and seeded on the β-TCP scaffolds synchronously. The cell viability remained unchanged after SECCS processing. Clinically, all patients obtained satisfactory bone healing. Thus, without in vitro culture, the SECCS can produce bioactive MSC/β-TCP composites for bone regeneration during surgery. The SECCS represents a convenient, rapid, low-cost, and safe method for bone regeneration.
What problem does this paper attempt to address?